NEW*NCI Announces New Funding to Support TCGA
The National Cancer Institute (NCI) has announced a new funding opportunity to support TCGA. This funding opportunity announcement (FOA) is soliciting applications for Genome Characterizations Centers and Genome Data Analysis Centers. A pre-application meeting for all interested prospective applicants will be held January 29, 2009, in person and via web cast with NCI staff to discuss the goals and objectives for the TCGA Research Network, the application content, and financial questions.
Learn more >>
The Cancer Genome Atlas Reports First Results of Comprehensive Study of Brain Tumors: Large-Scale Effort Identifies New Genetic Mutations, Core Pathways
The Cancer Genome Atlas Research Network reported the first results of its large-scale, comprehensive study of the most common form of brain cancer, glioblastoma (GBM) in the Sept. 4, 2008 advance online edition of the journal Nature. Among the TCGA findings are the identification of many gene mutations involved in GBM, including three previously unrecognized mutations that occur with significant frequency; and the delineation of core pathways disrupted in this type of brain cancer. One of the most exciting results is an unexpected observation that points to a potential mechanism of resistance to a common chemotherapy drug used for brain cancer.
Learn more >>
TCGA Moving Molecular Oncology Forward
The Cancer Genome Atlas (TCGA) pilot project, a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), has made valuable progress as new data is continually generated and shared internationally among researchers. With new technologies and tools being developed, TCGA is enabling researchers to delve further into the molecular machinery of cancer with greater precision and efficiency.
Learn more >>
|